06/01/2020
New Combination Treatment for mCRPC Heads to Phase 3 Trial
At the GU-ASCO meeting held earlier this year, Dr. Neeraj Agarwal of the Huntsman Cancer Center at the University of Utah presented results of a Phase 1b trial of combination therapy with two drugs (cabozantinib + atezolizumab) in metastatic castration resistant prostate cancer (mCRPC). Many treatments for mCRPC exist, but. Read More
05/20/2020
Two New Treatments Approved For Advanced Prostate Cancer
This has been a truly historic week, with two new treatment options receiving FDA approval for men with advanced prostate cancer. On Friday, 5/15/20, the FDA approved rucaparib, a new medication to treat some patients with advanced prostate cancer. Then, on Tuesday, 5/19/20, olaparib was approved by the FDA for certain. Read More
05/18/2020
HITCH: Years of PCF-Funded Research and Discovery Lead to New PCF-VA Clinical Trial for Veterans With COVID-19
Although the global pandemic-causing coronavirus called COVID-19 has only recently taken over all our lives – killing more Americans in just eight weeks than died in the entire Vietnam War – scientists already know quite a lot about it. For instance, they know how the virus sneaks into the nose,. Read More
05/05/2020
ADT and Your Health During COVID-19
So, there’s a global pandemic. If you’re on androgen deprivation therapy (hormone therapy, or ADT) for prostate cancer, you may think, “I’ve got enough to worry about.” Well - you may not believe this - but we actually have some good news for you: it looks like one of the. Read More
Radiation Treatment for Prostate Cancer During the COVID-19 Pandemic
A team of researchers led by PCF-funded investigator Dr. Dan Spratt has released a framework for the use of radiation oncology in prostate cancer during COVID-19. The team rapidly reviewed the available literature and issued recommendations for clinicians when considering radiation therapy for prostate cancer patients. The goal is to. Read More
04/14/2020
Considering Joining a Prostate Cancer Support Group? Here’s What You Need to Know
When we at PCF and Us TOO first started collaborating on this article, it was business-as-usual: once a man, his partner, or loved one was ready to join a support group, they could call around or look online to find a nearby group, confirm the details, and meet a roomful. Read More
04/07/2020
Treatment of Oligometastasis: Update from the ORIOLE Study
To the growing list of strategies for attacking prostate cancer, let us add this approach: Whack-a-Mole. That’s how Johns Hopkins radiation oncologist Phuoc Tran, M.D., Ph.D., describes it to his patients. The actual scientific name for this highly sophisticated strategy is stereotactic ablative radiotherapy (SABR, highly focused, intense doses of. Read More
03/24/2020
What If Your Treatment is Delayed?
So, you’ve got localized prostate cancer, you’ve decided to get it treated with either surgery or radiation, and you have steeled yourself to get on with it. You’ve been through a lot already: from the PSA results to coming to terms with the fact that you have prostate cancer. You. Read More
03/12/2020
Breaking Down Barriers to Treatment – Literally
In the past few years, several new treatment options have become available to patients with advanced prostate cancer. Radionuclide therapy is a new class of treatments which uses a hybrid “targeting” molecule to bind to a target protein on prostate cancer cells and a radioactive “killing” molecule to destroy the. Read More
03/10/2020
Surgery, Short-Course ADT, Radiation, and Remission
In 2013, Allan Odden was 70, newly retired from a career as a college professor, in good health, walking four miles a day, playing golf and bridge, and ready to enjoy many more years with his wife, Eleanor. When he went for his yearly physical, his doctor asked if he. Read More